期刊文献+

VEGF水平与恶性胸腔积液的相关性研究 被引量:22

Study on correlation between VEGF level and malignant pleural effusion
下载PDF
导出
摘要 目的探讨血清及胸腔积液中VEGF水平在良、恶性肿瘤中的诊断价值,并评价VEGF-A,C,D在诊断恶性胸腔积液中的临床应用。方法从滨州医学院附属医院住院治疗的患者中,选择肺癌且伴有胸腔积液者,共34例,收集其血清及胸腔积液,采用双抗体夹心ELISA法检测胸腔积液及血清VEGF及VEGF-A,C,D浓度。同时测定34例良性胸腔积液患者的血清及胸腔积液VEGF水平情况,并进一步检测恶性浆膜腔积液患者外周血清,积液上清VEGF-A,C,D的浓度。结果血清及胸腔积液VEGF水平恶性组均显著高于良性组(P<0.05)。另外,初治前肺癌患者血清及胸腔积液VEGF水平,有远处转移组明显高于尚未有远处转移组(P<0.05)。VEGF水平与恶性胸腔积液存在相关性(r=0.878,P<0.05)。VEGF水平与良性胸腔积液无相关性。血清s VEGF-A含量在恶性组及良性组无统计学差别。积液上清p VEGF-A含量在恶性组高于良性积液组(P<0.05),在恶性积液中显示p VEGF-A明显高于s VEGF-A水平(P<0.05)。血清s VEGF-C,s VEGF-D含量在恶性组及良性组无统计学差别。积液上清p VEGF-C,p VEGF-D含量在恶性组及良性组无统计学差别。结论检测血清及胸腔积液中VEGF水平有助于良恶性胸腔积液的诊断和鉴别诊断。积液上清VEGF-A在良恶性积液有差异,提示可能成为良恶性积液的肿瘤标志物。 Objective Methods To explore the value of VEGF levels in serum and pleural effusion for diagnosis of benign and malignant tumors, and evaluate clinical value of VEGF-A, C, D in malignant pleural effusion.Methods Serum and pleural effusion of 34 cases patients with lung cancer were collected in our hospital, the application of ELISA method for the detection of VEGF level in serum and pleural effusion in patients with lung cancer and with benign pleural effusion.VEGF-A, C, D levels were detected.Results VEGF levels in serum and pleural effusion in malignant group were significantly higher than those in benign group(P〈0.05).In addition, patients with lung cancer before initial treatment, the VEGF levels in serum and pleural effusion of distant metastasis group were significantly higher than those of without distant metastasis group(P〈0.05).There was a correlation between the level of VEGF and the malignant pleural effusion(r=0.878, P〈0.05).No correlation existed between VEGF level and benign pleural effusion.The content of sVEGF-A in serum had no statistical difference in cancer group and benign group.Effusion supernatants of pVEGF-A content in lung cancer group were higher than those in benign effusion group(P〈0.05).pVEGF-A and sVEGF-A levels were similar in benign effusion group. Effusion supernatants pVEGF-A in malignant group was higher than that in benign effusion group(P〈0.05).pVEGF-A was significantly higher than that of sVEGF-A in malignant effusion(P〈0.05).Serum VEGF-C, VEGF-D content had no significant difference between cancer group and benign group. pVEGF-C, pVEGF-D content had no significant difference between cancer group and benign group.Conclusion Level of VEGF in serum and pleural effusion detection would help to diagnose and differentially diagnose benign and malignant pleural effusion.Effusion VEGF-A is different in benign and malignant effusion, which may become benign and malignant effusion tumor markers.
出处 《中国生化药物杂志》 CAS 2015年第3期141-143,共3页 Chinese Journal of Biochemical Pharmaceutics
关键词 胸腔积液 血管内皮生长因子 肿瘤 VEGF—A VEGF—C VEGF-D pleural effusion vascular endothelial growth factor tumor VEGF-A VEGF-C VEGF-D
  • 相关文献

参考文献16

  • 1Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions [ J ]. Chest, 2000, 117(1) :79-86.
  • 2Creaney J, Robinson BWS. Serum and pleural fluid biomarkers for mesothelioma[ J]. Curr Opin Pulm Med,2009,15 (4) :366-370.
  • 3Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years [ J ]. Eur J Cardiotilorac Surg, 2002,22 ( 2 ) : 298 -305.
  • 4SengerDR,Galli SJ,Dvorak AM,et al. Tumour cells secrete a vascular permeability factor that promotes accumulation of a scities fluid [ J ]. Science, 1983,219(4587 ) :983-985.
  • 5Grove CS ,Lee Y C. Vascular endothelial growth factor:the key mediator in pleural effusionformation [ J ]. Curr Opin Pulm Med, 2002,8 (4) : 294-301.
  • 6于浩,盛修贵,张师前.肿瘤淋巴管生成研究进展[J].中华肿瘤防治杂志,2013,20(8):637-640. 被引量:17
  • 7Ishii H,Yazawa T, Sato H, et al. Enhancement of pleura1 dissemination and lymph node metastasis of intrathoracic lung cancer ceils by vascular endothelial growth factors (VEGFs) [ J ]. Lung Cancer, 2004,45 ( 3 ) : 325-337.
  • 8Ma X,Yao Y, Yuan D, et al. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice[J]. PLoS One,2012,7(12) :e53449.
  • 9Mohammed KA, Nasreen N, Hardwick J, et al . Bacterial induction of pleural mesothelial monolayer barrier dysfunction [ J ]. Am J Physiol Lung Cell Mol Physiol,2001,281 (1) : 119-125.
  • 10Yano S, Herbst RS, Shinohara H, et al. Treatment for malignant pleural effusion of human lung adenocareinoma by inhibition of vascular endothelial growth factor receptor tyrosinc kinase phos-phorylation [ J ]. Clin Cancer Res,2000,6 (3) :957-965.

二级参考文献33

  • 1Mumprecht V,Detmar M. In vivo imaging of lymph node lym-phangiogenesis by immuno-positron emission tomography [J],Methods Mol Biol,2013,961:129-140.
  • 2Liu ZY,Qiu HO,Yuan XJ,et al. Suppression of lymphangiogene-sis in human lymphatic endothelial cells by simultaneously bloc-king VEGF-C and VEGF-D/VEGFR-3 with norcantharidin[J].Int J Oncol,2012,41(5) :1762-1772.
  • 3Wakisaka N,Hirota K,Kondo S,et al. Induction of lymphangio-genesis through vascular endothelial growth factor-C/vascularendothelial growth factor receptor 3 axis and its correlation withlymph node metastasis in nasopharyngeal carcinoma[J].Oral On-col,2012,48(8) :703-708.
  • 4Langheinrich MC. Schellerer V,Perrakis A,et al. Molecular mecha-nisms of lymphatic metastasis in solid tumors of the gastrointestinaltract[J].Int J Clin Exp Pathol,2012,5(7) :614-623.
  • 5Zaganelli FL,Carvalho FM,Almeida BG,et al. Intratumoral lym-phatic vessel density and clinicopathologic features of patientswith early-stage cervical cancer after radical hysterectomy[J].IntJ Gynecol Cancer,2010 .20(7) :1225-1231.
  • 6Maula SM* Luukkaa M,Grenman R,et al. Intratumoral lymphaticsare essential for the metastatic spread and prognosis in squamous cellcarcinomas of the head and neck region[J].Cancer Res,2003,63(8):1920-1926.
  • 7Sipos B,Klapper W,Kruse ML.et al. Expression of lymphangiogenicfactors and evidence of intratumoral lymphangiogenesis in pancreaticendocrine tumors[J].Am J Pathol,2004,165(4) .1187-1197.
  • 8Cimpean AM,Mazuru V,Saptefrati L,et al. Prox 1,VEGF-C andVEGFR3 expression during cervical neoplasia progression as evi-dence of an early lymphangiogenic switch [J]. Histol His-topathol,2012,27(12) :1543-1550.
  • 9Xiong Y,Cao LP,Rao HL,et al. Clinical significance of peritumorallymphatic vessel density and lymphatic vessel invasion detected byD2-40 immunostaining in FIGO Ibl-IIa squamous cell cervical cancer[J].Int J Gynecol Cancer,2010,20(7) :1225-1231.
  • 10Padera TP,Kadambi A,di Tomaso E,et al. Lymphatic metasta-sis in the absence of functional intratumor lymphatics[J].Sci-ence,2002,296(5574) ,1883-1886.

共引文献182

同被引文献144

  • 1李岳勇,韦忠恒,钟秋红,吴英宁,姜秋兰,周石,汪建初.中药华蟾素对肝细胞肝癌TACE术后肝内复发和血清VEGF/TSGF表达的影响[J].辽宁中医杂志,2020,47(1):131-134. 被引量:22
  • 2赵建龙,王胐胐,李世朋,席守民,李文雅,丁雪贞.VEGF、LYVE-1在肝癌组织中的表达与意义[J].中国老年学杂志,2014,34(8):2167-2169. 被引量:10
  • 3周君,刘海玲,陈亦乐,文继舫,李龙,吴晓英.VEGF和miR-205及靶蛋白Ezrin和LaminA/C在卵巢癌中的表达及意义[J].中南大学学报(医学版),2014,39(2):142-150. 被引量:23
  • 4杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1520
  • 5孙瑜,王良兴,王惠军,李翊卫.VEGF、CD44_(V6)、MMP联合检测对良、恶性胸水的鉴别意义[J].温州医学院学报,2006,36(4):350-353. 被引量:6
  • 6Kazuhiro Kitamura,Kaoru Kubota,Masahiro Ando,Satoshi Takahashi,Nobuhiko Nishijima,Teppei Sugano,Masaru Toyokawa,Koji Miwa,Seiji Kosaihira,Rintaro Noro,Yuji Minegishi,Masahiro Seike,Akinobu Yoshimura,Akihiko Gemma.Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion[J]. Cancer Chemotherapy and Pharmacology . 2013 (2)
  • 7Ma Xingqun,Yao Yanwen,Yuan Dongmei,Liu Hongbing,Wang Shouju,Zhou Changsheng,Song Yong.Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice. PloS one . 2013
  • 8Daye Cheng,Hong Kong,Yunhui Li.??Prognostic values of VEGF and IL-8 in malignant pleural effusion in patients with lung cancer(J)Biomarkers . 2013 (5)
  • 9Erminia Massarelli,Amir Onn,Edith M. Marom,Christine M. Alden,Diane D. Liu,Hai T. Tran,Barbara Mino,Ignacio I. Wistuba,Saadia A. Faiz,Lara Bashoura,George A. Eapen,Rodolfo C. Morice,J. Jack Lee,Waun K. Hong,Roy S. Herbst,Carlos A. Jimenez.??Vandetanib and Indwelling Pleural Catheter for Non–Small-Cell Lung Cancer With Recurrent Malignant Pleural Effusion(J)Clinical Lung Cancer . 2014
  • 10Wen-ying Zhao,Dong-yun Chen,Jing-hua Chen,Zhao-ning Ji.??Effects of Intracavitary Administration of Endostar Combined with Cisplatin in Malignant Pleural Effusion and Ascites(J)Cell Biochemistry and Biophysics . 2014 (1)

引证文献22

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部